AlphaCrest Capital Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-19,363
| Closed | -$323K | – | 1242 |
|
|
2021
Q4 | $323K | Buy |
19,363
+10,695
| +123% | +$178K | 0.01% | 1238 |
|
|
2021
Q3 | $406K | Sell |
8,668
-26,293
| -75% | -$1.23M | 0.02% | 997 |
|
|
2021
Q2 | $2.13M | Buy |
34,961
+22,861
| +189% | +$1.39M | 0.09% | 342 |
|
|
2021
Q1 | $745K | Buy |
12,100
+6,300
| +109% | +$388K | 0.04% | 622 |
|
|
2020
Q4 | $412K | Buy |
+5,800
| New | +$412K | 0.03% | 765 |
|